Cite Filings / JAZZ / 0001628280-26-061978

Feed Companies Filings Check

Sign in

8-K

Current Report

Jazz Pharmaceuticals plc Filed 2026-09-15 Acc 0001628280-26-061978

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , jazz-20260915.htm

Around this filing

2026-09-23 8-K Material agreement · New debt or obligation
2026-09-15 8-K Regulation FD disclosure
2026-09-14 4 EVP & Chief Legal Officer sold 1,200 shares at $240.94 ($289,128)
2026-09-10 4 SVP, Technical Operations gave up 1,427 shares (to pay taxes)
2026-09-10 144 Sale of Securities
2026-09-10 4 President & CEO sold 2,000 shares at $243.03 ($486,060)
2026-08-31 8-K Material agreement · New debt or obligation · Unregistered share sale · Other events

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading jazz-20260915.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…